Renaissance Technologies’s OnKure Therapeutics, Inc. Class A Common Stock OKUR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $293K | Buy |
122,636
+80,773
| +193% | +$193K | ﹤0.01% | 3048 |
|
|
2025
Q1 | $180K | Sell |
41,863
-5,587
| -12% | -$24K | ﹤0.01% | 3096 |
|
|
2024
Q4 | $408K | Sell |
47,450
-2,703
| -5% | -$23.2K | ﹤0.01% | 2937 |
|
|
2024
Q3 | $853K | Buy |
50,153
+5,933
| +13% | +$101K | ﹤0.01% | 2542 |
|
|
2024
Q2 | $668K | Sell |
44,220
-15,110
| -25% | -$228K | ﹤0.01% | 2548 |
|
|
2024
Q1 | $985K | Buy |
59,330
+19,290
| +48% | +$320K | ﹤0.01% | 2496 |
|
|
2023
Q4 | $641K | Buy |
40,040
+36,440
| +1,012% | +$583K | ﹤0.01% | 2666 |
|
|
2023
Q3 | $274K | Sell |
3,600
-2,511
| -41% | -$191K | ﹤0.01% | 2974 |
|
|
2023
Q2 | $401K | Buy |
6,111
+3,551
| +139% | +$233K | ﹤0.01% | 2987 |
|
|
2023
Q1 | $153K | Sell |
2,560
-1,160
| -31% | -$69.3K | ﹤0.01% | 3367 |
|
|
2022
Q4 | $87K | Sell |
3,720
-580
| -13% | -$13.6K | ﹤0.01% | 3666 |
|
|
2022
Q3 | $144K | Buy |
4,300
+2,000
| +87% | +$67K | ﹤0.01% | 3490 |
|
|
2022
Q2 | $61K | Buy |
+2,300
| New | +$61K | ﹤0.01% | 3963 |
|